These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12127714)

  • 1. Comparative antimicrobial activity of lysosubtilin and its acid-resistant derivative, Fermosorb.
    Biziulevièius GA; Sukaitë V
    Int J Antimicrob Agents; 2002 Jul; 20(1):65-8. PubMed ID: 12127714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysosubtilin modification, Fermosorb, designed for polymeric carrier-mediated intestinal delivery of lytic enzymes: pilot-scale preparation and evaluation of this veterinary medicinal product.
    Biziulevicius GA; Zukaite V
    Int J Pharm; 1999 Oct; 189(1):43-55. PubMed ID: 10518684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibacterial spectrum of lisosubtilin G10X].
    Biziuliavichius GA; Shablinskas AI; Zhukaĭte VP; Kislukhina OV
    Antibiot Khimioter; 1989 Aug; 34(8):579-81. PubMed ID: 2511813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies on Polyferm and Fermosorb, two oral (ferment + sorbent) - type preparations designed for therapy/prophylaxis of intestinal infections in animal neonates.
    Biziulevicius GA; Zukaite V
    J Vet Pharmacol Ther; 2001 Dec; 24(6):433-8. PubMed ID: 11903874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo studies on lysosubtilin. 3. Efficacy for treatment of mastitis and superficial lesions of the udder and teats in cows.
    Biziulevichius GA; Lukauskas K
    Vet Res; 1998; 29(5):441-56. PubMed ID: 9779557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lysosubtilin G10x--a new antimicrobial agent for treatment and prophylaxis. Physico-chemical properties].
    Biziuliavichius GA; Shablinskas AI; Zhukaĭte VP; Kislukhina OV
    Antibiot Med Biotekhnol; 1987 May; 32(5):331-3. PubMed ID: 3111353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication of oral acid resistant Fermosorb (Ferment + sorbent)-type preparations can be simplified using industrial Bacillus subtilis culture filtrates as an enzyme source.
    Biziulevicius GA; Zukaite V
    Int J Pharm; 2000 Aug; 204(1-2):43-6. PubMed ID: 11011984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of lysosubtilin per os in mice, rabbits and calves.
    Biziulevichius GA; Arestov IG
    Vet Res; 1997; 28(4):385-95. PubMed ID: 9257446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo studies on lysosubtilin. 2. Efficacy for treatment of post-partum endometritis in cows.
    Biziulevichius GA; Lukauskas K
    Vet Res; 1998; 29(1):47-58. PubMed ID: 9559520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of lytic enzyme production resulting from replacement of the usual morphological variant of industrial lysosubtilin producer.
    Biziulevichius GA; Normantiene T
    Lett Appl Microbiol; 1997 Feb; 24(2):133-5. PubMed ID: 9081307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo studies on lysosubtilin. I. Efficacy for prophylaxis and treatment of gastrointestinal disorders in newborn calves.
    Biziulevichius GA; Arestov IG
    Vet Res; 1997; 28(1):19-35. PubMed ID: 9172838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular proteases increase tolerance of Bacillus subtilis to nafcillin.
    Jolliffe LK; Doyle RJ; Streips UN
    Antimicrob Agents Chemother; 1982 Jul; 22(1):83-9. PubMed ID: 6812497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acid-catalysed synthesis of 7-azaindoles from 3-alkynyl-2-aminopyridines and their antimicrobial activity.
    Leboho TC; van Vuuren SF; Michael JP; de Koning CB
    Org Biomol Chem; 2014 Jan; 12(2):307-15. PubMed ID: 24225656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-specific immunity-enhancing effects of tryptic casein hydrolysate versus Fermosorb for treatment/prophylaxis of newborn calf colibacillosis.
    Biziulevicius GA; Zukaite V; Normantiene T; Biziuleviciene G; Arestov IG
    FEMS Immunol Med Microbiol; 2003 Nov; 39(2):155-61. PubMed ID: 14625099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel hydroxamic acid-containing antibiotic produced by a Saharan soil-living Streptomyces strain.
    Yekkour A; Meklat A; Bijani C; Toumatia O; Errakhi R; Lebrihi A; Mathieu F; Zitouni A; Sabaou N
    Lett Appl Microbiol; 2015 Jun; 60(6):589-96. PubMed ID: 25754683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolation and characterization of the lytic enzyme from Bacillus subtilis 797].
    Borovikova VP; Aksenovskaia VE; Lavrenoza GI; Kislukhina OV; Kaluniants KA
    Biokhimiia; 1980 Aug; 45(8):1524-33. PubMed ID: 6786375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8006-I, an antibiotic from Amblyosporium spongiosum (Pers.) Hughes sensu Pirozynski. II. Biological properties.
    Rak G; Anke H
    J Antibiot (Tokyo); 1982 Apr; 35(4):436-40. PubMed ID: 6178718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial spectrum of triclosan, a broad-spectrum antimicrobial agent for topical application. II. Comparison with some other antimicrobial agents.
    Regös J; Zak O; Solf R; Vischer WA; Weirich EG
    Dermatologica; 1979; 158(1):72-9. PubMed ID: 761692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological studies on 1,2-benzisothiazole derivatives V. Antimicrobial properties of N-alkanoic, N-arylalkanoic and N-aryloxyalkanoic derivatives of 1,2-benzisothiazolin-3-one: QSAR study and genotoxicity evaluation.
    Mor M; Zani F; Mazza P; Silva C; Bordi F; Morini G; Plazzi PV
    Farmaco; 1996 Jul; 51(7):493-501. PubMed ID: 8765672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the in-vitro antimicrobial activity of oleuropein and hydroxytyrosol.
    Bisignano G; Tomaino A; Lo Cascio R; Crisafi G; Uccella N; Saija A
    J Pharm Pharmacol; 1999 Aug; 51(8):971-4. PubMed ID: 10504039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.